Inpatient and Outpatient Orderable
Insulin-like Growth Factor-binding Protein 3 (IGFBP-3)
Build info
Synonyms
|
- INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 3 (IGFBP-3)
- ILGFBP3
- IGF BINDING PROTEIN-3
- IGFBP3
- INSULIN LIKE GF BINDING PROT 3
- SOMATOMEDIN C BINDING PROTEIN
- IGFBP-3
- LAB10850
|
Procedure Name
|
INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 3 (IGFBP-3)
|
Procedure Master Number
|
LAB10850
|
Procedure ID
|
114208
|
Clinical Info
|
The insulin-like growth factor (IGF) system plays a critical role in the growth and differentiation of normal and malignant cells.
|
Specimen Sources
|
Blood, Arterial
Blood, Capillary
Blood, Central Line
Blood, Venous
|
Specimen Types
|
Blood
|
Container
|
Gold Top Tube
|
Collection Instructions
|
Container/Tube: Gold top tube
Specimen: 1 mL (minimum volume: 0.2 mL)
Transport Temperature: Refrigerated
Stability: 14 Days Room Temperature or Refrigerated
90 Days Frozen
Special Instructions
This test may exhibit interference when sample is collected from a person who is consuming a supplement with a high dose of biotin (also termed as vitamin B7 or B8, vitamin H, or coenzyme R). It is recommended to ask all patients who may be indicated for this test about biotin supplementation. Patients should be cautioned to stop biotin consumption at least 72 hours prior to the collection of a sample.
|
Specimen Volume
|
1 mL (minimum volume: 0.2 mL)
|
Transport Instructions
|
Refrigerated
|
Specimen Stability
|
14 Days Room Temperature or Refrigerated
90 Days Frozen
Special Instructions
This test may exhibit interference when sample is collected from a person who is consuming a supplement with a high dose of biotin (also termed as vitami
|
Methodology
|
Immunochemiluminometric Assay (ICMA)
|
Days Performed
|
TAT: 2-4 Days
|
Performing Laboratory
|
LabCorp of America
|
CPT
|
83520
LOINC Code: 2483-6
|
PDM
|
5900855
|
Only Orderable at Locations:
|
Orderable Everywhere
|
Results
|
| Component Name |
Base Name |
Common Name |
External Name |
| INSULIN LIKE GF BINDING PROTEIN 3 |
IGF3 |
INSULIN LIKE GF BINDING PROTEIN 3 |
Insulin Like GF Binding Protein 3 |
|
Result Interpretation
Age
|
Male / Female
(mg/L)
|
Age
|
Male / Female
(mg/L)
|
1-7 d
|
ND-0.7
|
17 y
|
3.2-8.7
|
8-15 d
|
0.5-1.4
|
18 y
|
3.1-7.9
|
15 d to 1 y
|
0.7-3.6
|
19 y
|
2.9-7.3
|
2 y
|
0.8-3.9
|
20 y
|
2.9-7.2
|
3 y
|
0.9-4.3
|
21-25 y
|
3.4-7.8
|
4 y
|
1.0-4.7
|
26-30 y
|
3.5-7.6
|
5 y
|
1.1-5.2
|
31-35 y
|
3.5-7.0
|
6 y
|
1.3-5.6
|
36-40 y
|
3.4-6.7
|
7 y
|
1.4-6.1
|
41-45 y
|
3.3-6.6
|
8 y
|
1.6-6.5
|
46-50 y
|
3.3-6.7
|
9 y
|
1.8-7.1
|
51-55 y
|
3.4-6.8
|
10 y
|
2.1-7.7
|
56-60 y
|
3.4-6.9
|
11 y
|
2.4-8.4
|
61-65 y
|
3.2-6.6
|
12 y
|
2.7-8.9
|
66-70 y
|
3.0-6.2
|
13 y
|
3.1-9.5
|
71-75 y
|
2.8-5.7
|
14 y
|
3.3-10.0
|
76-80 y
|
2.5-5.1
|
15 y
|
3.5-10.0
|
81-85 y
|
2.2-4.5
|
16 y
|
3.4-9.5
|
|
Tanner Stage
|
I
|
1.3-6.3
|
II
|
2.4-6.7
|
III
|
3.3-9.1
|
IV
|
3.5-8.6
|
V
|
2.7-8.9
|
|
Forms
|
|
